Second, the subcellular dynamics of NR4A1, particularly its nucleocytoplasmic shuttling under BA treatment, warrant investigation via spatial proteomics.32 These limitations, however, do not diminish the present findings but rather map a roadmap for future studies. The gene discussed is NR4A1; the disease is breast angiosarcoma.